When did the new requirements for nucleotide and amino acid sequence disclosures in patent applications take effect?

The new requirements for nucleotide and amino acid sequence disclosures in patent applications took effect on July 1, 2022. This is clearly stated in MPEP 2412.02(a):

“[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]”

These requirements apply to patent applications filed on or after this date that contain nucleotide and/or amino acid sequence disclosures. The new rules align with WIPO Standard ST.26, which replaced the previous WIPO Standard ST.25.

To learn more:

• effective date
• sequence disclosure requirements
• patent application
• WIPO Standard ST.26
• USPTO rules